Davíð O. Arnar

17.2k total citations
58 papers, 2.0k citations indexed

About

Davíð O. Arnar is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Davíð O. Arnar has authored 58 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Davíð O. Arnar's work include Cardiac Arrhythmias and Treatments (20 papers), Cardiac electrophysiology and arrhythmias (18 papers) and Cardiac pacing and defibrillation studies (17 papers). Davíð O. Arnar is often cited by papers focused on Cardiac Arrhythmias and Treatments (20 papers), Cardiac electrophysiology and arrhythmias (18 papers) and Cardiac pacing and defibrillation studies (17 papers). Davíð O. Arnar collaborates with scholars based in Iceland, United States and Germany. Davíð O. Arnar's co-authors include Vilmundur Guðnason, Thor Aspelund, M.J. Pekka Raatikainen, Kāri Stefánsson, Guðmundur Þorgeirsson, James B. Martins, Béla Merkely, Gerhard Hindricks, A. John Camm and Sigurður Sigurdsson and has published in prestigious journals such as Circulation, Nature Genetics and Blood.

In The Last Decade

Davíð O. Arnar

54 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Davíð O. Arnar Iceland 21 1.6k 309 205 195 117 58 2.0k
João D. Fontes United States 24 955 0.6× 185 0.6× 257 1.3× 107 0.5× 42 0.4× 33 1.5k
Shih‐Ann Chen Taiwan 31 2.7k 1.7× 294 1.0× 214 1.0× 262 1.3× 120 1.0× 190 3.0k
Sylvain Planté Canada 17 689 0.4× 213 0.7× 53 0.3× 342 1.8× 147 1.3× 35 1.2k
Beatriz López‐Melgar Spain 18 618 0.4× 136 0.4× 144 0.7× 282 1.4× 185 1.6× 42 1.3k
George Kochiadakis Greece 24 1.4k 0.8× 183 0.6× 102 0.5× 385 2.0× 122 1.0× 108 1.7k
José M. Mendiguren Spain 17 595 0.4× 125 0.4× 170 0.8× 308 1.6× 158 1.4× 20 1.3k
Dimitrios Patoulias Greece 22 547 0.3× 283 0.9× 176 0.9× 393 2.0× 109 0.9× 211 1.6k
José R. Matos‐Souza Brazil 19 738 0.5× 286 0.9× 301 1.5× 221 1.1× 174 1.5× 74 1.5k
Carl Timmermans Netherlands 29 2.6k 1.6× 156 0.5× 57 0.3× 193 1.0× 78 0.7× 98 2.8k
Valentina Milani Italy 18 473 0.3× 205 0.7× 174 0.8× 249 1.3× 186 1.6× 57 1.1k

Countries citing papers authored by Davíð O. Arnar

Since Specialization
Citations

This map shows the geographic impact of Davíð O. Arnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davíð O. Arnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davíð O. Arnar more than expected).

Fields of papers citing papers by Davíð O. Arnar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davíð O. Arnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davíð O. Arnar. The network helps show where Davíð O. Arnar may publish in the future.

Co-authorship network of co-authors of Davíð O. Arnar

This figure shows the co-authorship network connecting the top 25 collaborators of Davíð O. Arnar. A scholar is included among the top collaborators of Davíð O. Arnar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davíð O. Arnar. Davíð O. Arnar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arnar, Davíð O., Elías F. Guðmundsson, Þórdís Jóna Hrafnkelsdóttir, et al.. (2025). Effect of a digital health intervention on outpatients with heart failure: a randomized, controlled trial. European Heart Journal - Digital Health. 6(4). 749–762.
2.
Arnar, Davíð O., et al.. (2022). Improving outpatient care for heart failure through digital innovation: a feasibility study. Pilot and Feasibility Studies. 8(1). 242–242. 2 indexed citations
3.
Þórólfsdóttir, Rósa B., Garðar Sveinbjörnsson, Patrick Sulem, et al.. (2018). A rare missense mutation in MYH6 associates with non-syndromic coarctation of the aorta. European Heart Journal. 39(34). 3243–3249. 50 indexed citations
4.
Þórólfsdóttir, Rósa B., Garðar Sveinbjörnsson, Patrick Sulem, et al.. (2017). A Missense Variant in PLEC Increases Risk of Atrial Fibrillation. Journal of the American College of Cardiology. 70(17). 2157–2168. 56 indexed citations
5.
Arnar, Davíð O. & Runólfur Pálsson. (2017). Genetics of common complex diseases: a view from Iceland. European Journal of Internal Medicine. 41. 3–9. 2 indexed citations
6.
7.
Skúladóttir, Gudrún V., Arieh S. Cohen, Davíð O. Arnar, et al.. (2016). Plasma 25-hydroxyvitamin D2 and D3 levels and incidence of postoperative atrial fibrillation. Journal of Nutritional Science. 5. e10–e10. 17 indexed citations
8.
Raatikainen, M.J. Pekka, Davíð O. Arnar, Béla Merkely, A. John Camm, & Gerhard Hindricks. (2016). Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association. EP Europace. 18(suppl 3). iii1–iii79. 47 indexed citations
9.
Önundarson, Páll T., Charles W. Francis, Ólafur S. Indridason, et al.. (2015). Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial. The Lancet Haematology. 2(6). e231–e240. 22 indexed citations
10.
11.
Arnar, Davíð O., Thor Aspelund, Sigurður Sigurdsson, et al.. (2013). Atrial Fibrillation is Associated With Reduced Brain Volume and Cognitive Function Independent of Cerebral Infarcts. Stroke. 44(4). 1020–1025. 125 indexed citations
12.
Arnar, Davíð O., Ólafur S. Indridason, Kristin Skogstrand, et al.. (2013). Do High Levels of n-3 Polyunsaturated Fatty Acids in Cell Membranes Increase the Risk of Postoperative Atrial Fibrillation?. Cardiology. 126(2). 107–114. 7 indexed citations
13.
Helgadóttir, Sólveig, et al.. (2012). Atrial fibrillation following cardiac surgery: risk analysis and long-term survival. Journal of Cardiothoracic Surgery. 7(1). 87–87. 123 indexed citations
14.
Aspelund, Thor, et al.. (2011). Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. EP Europace. 13(8). 1110–1117. 136 indexed citations
15.
Arnar, Davíð O., Gudrún V. Skúladóttir, Bjarni Torfason, et al.. (2010). Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?. EP Europace. 12(3). 356–363. 85 indexed citations
16.
Arnar, Davíð O., et al.. (2007). α-2 adrenergic antagonism enhances risk of ventricular tachycardia during acute ischemia. Scandinavian Cardiovascular Journal. 41(6). 378–385. 10 indexed citations
17.
Leósdóttir, Margrét, et al.. (2006). Health-related quality of life of patients with implantable cardioverter defibrillators compared with that of pacemaker recipients. EP Europace. 8(3). 168–174. 41 indexed citations
18.
Arnar, Davíð O., et al.. (2005). Overdrive pacing of early ischemic ventricular tachycardia: evidence for both reentry and triggered activity. American Journal of Physiology-Heart and Circulatory Physiology. 288(3). H1124–H1130. 8 indexed citations
19.
Arnar, Davíð O., John Cai, Hon-Chi Lee, & James B. Martins. (1998). Electrophysiologic Effects of Civamide (Zucapsaicin) on Canine Cardiac Tissue In Vivo and In Vitro. Journal of Cardiovascular Pharmacology. 32(6). 875–883. 9 indexed citations
20.
Arnar, Davíð O., et al.. (1993). Renovascular hypertension and coronary heart disease complicating essential thrombocythemia. European Heart Journal. 14(4). 576–578. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by João D. Fontes Breakdown of academic impact, for papers by Shih‐Ann Chen Breakdown of academic impact, for papers by Sylvain Planté Breakdown of academic impact, for papers by Beatriz López‐Melgar Breakdown of academic impact, for papers by George Kochiadakis Breakdown of academic impact, for papers by José M. Mendiguren Breakdown of academic impact, for papers by Dimitrios Patoulias Breakdown of academic impact, for papers by José R. Matos‐Souza Breakdown of academic impact, for papers by Carl Timmermans Breakdown of academic impact, for papers by Valentina Milani
Rankless by CCL
2026